Beijing Science Sun Pharmaceutical (300485.SZ) jumped 1.5% to CNY7.24, a 57-day high as market volatility builds. The company, which specialises in its cardiovascular and immunomodulating products, is resilient despite suffering from financial setback in recent periods. The market capitalization for the company is ¥3.43 billion with its share movement standing out as compared to forecasted fiscal year 2024 losses of a maximum of 88.7592 million yuan. Investors are following closely the recovery of the company and its potential expansion in its core pharma segments, as it moves through a competitive health care market environment.
Sources: MarketScreener, Moomoo, Reuters